首页> 外文期刊>The Lancet >Intensive speech and language therapy in patients with chronic aphasia after stroke: a randomised, open-label, blinded-endpoint, controlled trial in a health-care setting
【24h】

Intensive speech and language therapy in patients with chronic aphasia after stroke: a randomised, open-label, blinded-endpoint, controlled trial in a health-care setting

机译:中风后慢性失语症患者的密集语音和语言治疗:随机,开放标签,盲终点,治疗验治疗中的受控试验

获取原文
获取原文并翻译 | 示例
           

摘要

Background Treatment guidelines for aphasia recommend intensive speech and language therapy for chronic (>= 6 months) aphasia after stroke, but large-scale, class 1 randomised controlled trials on treatment effectiveness are scarce. We aimed to examine whether 3 weeks of intensive speech and language therapy under routine clinical conditions improved verbal communication in daily-life situations in people with chronic aphasia after stroke.
机译:背景技术对于失语症建议慢性(> = 6个月)患有慢性(> = 6个月)的密集语言治疗,但大规模,第1类关于治疗效果的随机对照试验是稀缺的。 我们旨在审查常规临床条件下3周的密集语音和语言治疗是否改善了中风后慢性失语症的日常生活情况中的口头沟通。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号